SEC Form 4 · accession 0001209191-15-019139
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rachel K. King
Officer — President, CEO · Director
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2015 | M | 50,000 | $1.12 | A | 167,206 | D | |
| Common StockF2,F3 | holding | — | — | — | 148,855 | I | By trusts | |
| Common Stock | holding | — | — | — | 1,741 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $1.12 | Feb 24, 2015 | M | 50,000 | D | — | Jan 4, 2021 | Common Stock | 50,000 | 297,580 | D |
Explanation of responses
- F1This total includes 8,500 shares previously held by The Rachel K. King 2013 GRAT that were transferred to the reporting person on September 17, 2014 and are now owned directly by the reporting person.
- F2This total excludes the 8,500 shares transferred to the reporting person as described in footnote (1).
- F3These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Connor A. King 1988 Trust, 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust and 127,781 shares are held by The Rachel K. King 2013 GRAT.
- F4Fully vested and exercisable.